Company / Depreciation & Amortization
Collegium Pharmaceutical, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$4.2M
FY2025
5-year range
$1.7M / $4.2M
FY2021-FY2025
Trend
+8.5%
vs FY2024
Sector context
#84 of 177
Health Care
What the data says
At $4M, Collegium Pharmaceutical, Inc.'s depreciation & amortization ranks #94 of 177 in the Health Care sector. Depreciation & Amortization has increased for 6 consecutive years, from $731,000 in FY2019 to $4M in FY2025.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of +36.9%.
Increased from $3M to $4M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +15.9%
- 5-Year CAGR
- +36.9%
- 10-Year CAGR
- -
Sector benchmark
#94 of 177 in Health CareTop 53% of 177This company $4.2M Sector average $204.7M
▼
-98.0% below sector average
Key checks
Key Insights
- Collegium Pharmaceutical, Inc.'s depreciation & amortization has grown for 6 consecutive years.
- 5-year CAGR of +36.9%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 8.5% year-over-year.
- Ranks #84 out of 177 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.2M | +8.5% |
| FY2024 | $3.9M | +10.3% |
| FY2023 | $3.5M | +30.3% |
| FY2022 | $2.7M | +54.6% |
| FY2021 | $1.7M | +99.5% |
| FY2020 | $870.0K | +19.0% |
| FY2019 | $731.0K | -31.9% |
| FY2018 | $1.1M | +528.1% |
| FY2017 | $171.0K | -73.9% |
| FY2016 | $655.0K | +283.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026